Havn Life Logo

Havn Life

CSE: HAVN | OTC: HAVNLF

HAVN Life Sciences  is a biotechnology company focused on standardized, quality-controlled extraction of psychoactive compounds from plants and fungi, and the development of natural health care products from non-regulated compounds. They went public in September 2020.

Havn Life Sciences
$0.8700
2.35%
$0.0200

There is a tremendous opportunity to transform and enhance the healthcare and wellness space with psychedelic medicine, and the time is now to lay the foundations for what is likely to be a significant industry. Our multidisciplinary team is focused on laying the groundwork by developing quality controls and methodology for research and the medical supply chain.

Tim Moore, Co-CEO

Join our Newsletter

Get the latest Company updates delivered to straight to your inbox.